[{"Assets_0_Q1_USD":15757500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":698000000.0,"NetIncomeLossConverted_1_Q1_USD":624600000.0,"StockholdersEquity_0_Q1_USD":12133000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":115100000.0,"EarningsPerShareBasic_1_Q1_USD":5.69,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":109800000.0,"EarningsPerShareDiluted_1_Q1_USD":5.43,"RevenuesConverted_1_Q1_USD":1828200000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200505"}]